Zyus Life Sciences Quote - ZYUS

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.76

Bid

0.76

Ask

0.80

Volume

6,012

0.76 Day's Range 0.77

0.00 52 Week Range 0.00

Market Cap

53.844M

Previous Close

0.80

Open

0.77

Last Trade

1000

0.76

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

70,847,000

Dividend Yield

PE Ratio

-1.26

Earnings Per Share (EPS)

-0.6

Revenue

351k

Net Profit

-42.59M

Sector

Pharmaceutical Preparations

Industry

Oil And Gas Field Expl Svcs

Website

www.zyus.com

Headquarters

Toronto, Ontario, Can

Founded

2023

Zyus Life Sciences Corporation is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker ZYUS. The last closing price for Zyus Life Sciences was $0.80. Over the last year, Zyus Life Sciences shares have traded in a share price range of $ 0.00 to $ 0.00.

Zyus Life Sciences currently has 70,847,000 shares outstanding. The market capitalization of Zyus Life Sciences is $56.68 million. Zyus Life Sciences has a price to earnings ratio (PE ratio) of -1.26.

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Insert as subheadline: NOT FOR DISTRIBUTION TO U.S...

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSXV: ZYUS) is pleased to announce that Brent Zettl, President and CEO of ZYUS, will...

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Receives Patent from United States Patent and Trademark Office (“USPTO”) Supporting ZYUS’ Lead Drug Candidate ZYUS Life Sciences Corporation...

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

Dr. Clarke Joins ZYUS’ Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management ZYUS Life Sciences Corporation...

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced team ZYUS Life Sciences Corporation (the...

TSX Venture Exchange Stock Maintenance Bulletins

TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, Dec. 28, 2023 VANCOUVER, BC, Dec. 28, 2023 /CNW/ - TSX VENTURE...

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain ZYUS Life Sciences Corporation ("ZYUS" or...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ZYUS - Frequently Asked Questions (FAQ)

What is the current Zyus Life Sciences share price?

The current share price of Zyus Life Sciences is $ 0.76

How many Zyus Life Sciences shares are in issue?

Zyus Life Sciences has 70,847,000 shares in issue

What is the market cap of Zyus Life Sciences?

The market capitalisation of Zyus Life Sciences is CAD 56.68M

What is the 1 year trading range for Zyus Life Sciences share price?

Zyus Life Sciences has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Zyus Life Sciences?

The price to earnings ratio of Zyus Life Sciences is -1.26

What is the cash to sales ratio of Zyus Life Sciences?

The cash to sales ratio of Zyus Life Sciences is 152

What is the reporting currency for Zyus Life Sciences?

Zyus Life Sciences reports financial results in CAD

What is the latest annual turnover for Zyus Life Sciences?

The latest annual turnover of Zyus Life Sciences is CAD 351k

What is the latest annual profit for Zyus Life Sciences?

The latest annual profit of Zyus Life Sciences is CAD -42.59M

What is the registered address of Zyus Life Sciences?

The registered address for Zyus Life Sciences is 3400-22 ADELAIDE STREET W, TORONTO, ONTARIO, M5H 4E3

What is the Zyus Life Sciences website address?

The website address for Zyus Life Sciences is www.zyus.com

Which industry sector does Zyus Life Sciences operate in?

Zyus Life Sciences operates in the OIL AND GAS FIELD EXPL SVCS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WAV.HPepcap Resources Inc	$ 0.02 (100.00%)	11k
WAVEWaverley Pharma Inc	$ 0.02 (100.00%)	3k
MTN.HMartina Minerals Corp	$ 0.07 (100.00%)	110k
RUN.HRunning Fox Resource Corp	$ 0.01 (100.00%)	5k
CEN.HClaren Energy Corp	$ 0.85 (88.89%)	166.24k
ATYAtico Mining Corp	$ 0.045 (-67.86%)	1.18M
ZENI.PZenith Captal Corporation	$ 0.05 (-52.38%)	20.5k
TVITVI Pacific Inc	$ 0.005 (-50.00%)	1,000
KUR.HKure Technologies Inc	$ 0.05 (-50.00%)	2.92k
NIR.HNoble Iron Inc	$ 0.01 (-50.00%)	6k
NOBNoble Mineral Exploration Inc	$ 0.045 (28.57%)	2.48M
OMGOmai Gold Mines Corp	$ 0.31 (-6.06%)	1.96M
GBUGabriel Resources Ltd	$ 0.085 (-19.05%)	1.72M
RSLVReyna Silver Corp	$ 0.065 (-7.14%)	1.68M
WRLGWest Red Lake Gold Mines Ltd	$ 0.57 (-5.00%)	1.52M

NYBob 3 minutes ago

Trump Didn’t See This Coming: Canada to Blocking US Free Access to Alaska: 1.2M views ·
1.2M views · 15 hours ago.

https://1a-1791.com/video/fwe2/5b/s8/1/s/d/M/q/sdMqy.oq1b.2-small-Trump-Didnt-See-This-Coming.jpg

https://rumble.com/v6qbhsi-trump-didnt-

EBS NCI

NYBob 6 minutes ago

EBS NCI

Truth and Transparency 11 minutes ago

Let’s be honest, Mark and Jim have an awful track record for maintaining shareholder value!

Ppastis 13 minutes ago

How does it feel when you know everything in advance ? You must have a lmade a lot of money ! ( but still on this board every day ??? Strange ? Non? ) Can you give me e few more things that will happen in the future ? I will be greatful the rest of my life !!

LWLG

MiamiGent 17 minutes ago

Info Wars reporter Jamie White has been murdered leaving work down in Austin Texas.
Laura Loomer betta get bodyguards.
She does tremendous investigative reporting, like just digging to find Reid Hoffman has contributed to groups funding the organization violently attacking Elon's store

eagle8 17 minutes ago

Wiz888999
@ODB123
🔥🚨 DTCC is officially in the HOT SEAT! 🚨🔥

Court orders them to hand over records on daily failures to deliver, clearing data, and all that behind-the-scenes broker magic.

The receipts are coming out, and so

NWBO

valleybenedetto 19 minutes ago

🤦🤦🤦

MRES

Vashi 19 minutes ago

Still Holding 21k Fnma.
Confused weather to sell or hold..Loosing.
Any advice.?

FNMA

TAKEARIDE 19 minutes ago

They have been diluting since that letter to shareholder... Incredible.

TKMO

valleybenedetto 20 minutes ago

Is this a serious post or sarcasm?

ASRE

DocLee 32 minutes ago

Thanks, Doc.

I would hope and expect that by now any neurosurgeon worth his salt would know that material for possible use in the manufacture of DVax-L has specific storage criteria.

I just find the whole thing sad; an eminent man apparently turning his back on a non

NWBO

LWLG-Netherlands 41 minutes ago

Another loser that already knows that it’s going to be bad news on Thursday. Get a break shortie. You are just nervous 🤡 We know what we own and we will get paid. Get out now or stay stupid 👋👋👋

LWLG

Seminole Red 42 minutes ago

tyty, signed up

Seminole Red 44 minutes ago

https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/483634955_655043383699142_8844683204789749705_n.jpg?_nc_cat=102&ccb=1-7&_nc_sid=833d8c&_nc_ohc=xkUqNgSykokQ7kNvgE-CVcA&_nc_oc=AdiVBrtENVPTlp1_ik1iB2c3dEWzK9XwmUQkY5hTteJAGOGLT2_vrlyrdTktcx0Vk2KGPlfDPDX0esCNQyZ0mrHs&_nc_zt=23&_nc_ht=scontent-mia3-2.x

236T568 45 minutes ago

Why there’s never been a better time to be anti-American

https://www.msn.com/en-in/news/world/ar-AA1AAwJH

MiamiGent 45 minutes ago

Truenorth2016 46 minutes ago

It appears that GCAN CEO Aitan Zacharin has some kind of patented AI Driven Technology that "WE" ... Yes "WE" use everyday on Social Media platforms like, Tik-Tok, Google, Meta, Unity & Applivan, etc...and we dont even know the tech belongs to GCAN CEO Aitan Zacharin.
This now explains why he

GCAN

Jimmy Joe 48 minutes ago

I have no memory of him posting that whatsoever

https://investorshub.advfn.com/uimage/uploads/2025/3/11/xpxwidownload.jpg

Sargent Stock_Barber.

😸😄😸😆😸🤣😸😂😹😂😹

DBMM

Invest ONE1 52 minutes ago

"Watch it Grow"..... Bahahahahahaha!!!! What a scam! I'm guessing the "rodman" nut had to get a second job!

VSPC

Richard H2 53 minutes ago

Time for ASRE to invest in a diesel Genset 😅🤣😂

ASRE

wagner 54 minutes ago

Still the misleading communication from the company since "years"

We don't want a "close"

2025 will this storytelling end in good way or another...

Just my opinion

darron427 56 minutes ago

Once it falls again , and it will with this market being so volatile and uncertain right now, next dump will be in the 40s gap filled or not. Imo. If they don't do something to counter the Federal Reserve manipulation of the USD and all this thrashing and cutting of Federal govt, I don't see how th

BTCUSD

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Zyus Life Sciences Corporation (ZYUS)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About Zyus Life Sciences Corporation

Ask ADVFN Intelligence (AI)

ZYUS Latest News

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

TSX Venture Exchange Stock Maintenance Bulletins

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Zyus Life Sciences Corporation (ZYUS) Share Price

Zyus Life Sciences Corporation (ZYUS)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About Zyus Life Sciences Corporation

Ask ADVFN Intelligence (AI)

ZYUS Latest News

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

TSX Venture Exchange Stock Maintenance Bulletins

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS